FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

14674711000001104: Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50952801000001113 Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50952901000001119 Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Is a Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Is a Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release powder for inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Is a Seretide Accuhaler true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Is a Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) 60 dose Is pack of False Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) 60 dose Has AMP True Seretide 250 Accuhaler (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start